Standard chemoradiation in combination with VEGF targeted therapy for glioblastoma results in progressive gray and white matter volume loss

Morgan Prust(Harvard University), Jörg Dietrich(Massachusetts General Hospital), Tracy T. Batchelor(Brigham and Women's Hospital), Elizabeth R. Gerstner(University of California, Los Angeles), Pavlina Polaskova(Harvard–MIT Division of Health Sciences and Technology), Kourosh Jafari‐Khouzani(Harvard University), Jayashree Kalpathy–Cramer(University of Colorado Denver)
Neuro-Oncology
November 14, 2017
Cited by 19


Related Papers